查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2122847

水楊酸：市場佔有率分析、產業趨勢與統計、成長預測（2026-2031）

Salicylic Acid - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026 - 2031)
出版日期: | 出版商: Mordor Intelligence | 英文 130 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

根據 Mordor Intelligence 預測，水楊酸市場規模將從 2025 年的 1.2161 億美元成長到 2026 年的 1.2954 億美元，然後在 2031 年達到 1.7761 億美元，2026 年至 2031 年的複合年成長率為 6.52%。

水楊酸市場-IMG1

本報告按應用領域（醫藥、化妝品及個人護理、食品飲料及其他）、形態（粉末及晶體、液體）和地區（北美、歐洲、亞太、南美以及中東和非洲）進行細分。市場預測以美元計價。

全球水楊酸市場趨勢及洞察

製藥業對水楊酸的需求增加

醫藥領域的應用正透過拓展治療適應症和改進製劑技術來推動市場擴張。先進的遞送系統，特別是超分子製劑，與傳統製劑相比，能夠更有效地提高膠原蛋白密度並減少皮膚刺激，從而克服了以往阻礙其廣泛應用的諸多限制。醫藥領域的專利活動依然活躍，近期申請主要集中在增強生物利用度並最大限度減少胃腸道副作用的聯合治療，以及新型遞送機制。醫藥領域受益於完善的監管流程，以及人們對水楊酸在傳統皮膚科用途之外的抗炎作用的日益認可。此外，該化合物已確立的安全性以及已獲得的監管批准，正鼓勵生產商積極將水楊酸應用於各種製劑。河北實業集團和山東新華等主要供應商在全球藥用級水楊酸的生產中發揮著至關重要的作用。最後，受消費者對自我護理解決方案的偏好推動，含有水楊酸的非處方藥（OTC）激增，也顯著促進了市場成長。

對護膚和個人保健產品的需求不斷成長

消費者對經科學驗證的活性成分的偏好持續推動著水楊酸在化妝品配方中的應用。然而，日益嚴格的安全監管正在影響這種成分的使用方式。例如，歐盟委員會消費者安全科學委員會近期將兒童化妝品中水楊酸的濃度限制在0.1%以內（僅限外用）。這反映了人們對安全性的日益關注，儘管成人產品中仍允許使用更高的濃度。在美國，監管力道也不斷加強。例如，美國食品藥物管理局（食品藥物管理局）曾向Skin Beauty Solutions公司發出警告信，指出其一款未經批准的化學換膚產品含有高濃度水楊酸。這促使製造商更加重視開發安全且符合監管規定的配方。此外，《化妝品監管現代化法案》引入了新的註冊要求，並加強了合規標準和市場准入程序。化妝品和個人保健產品製造商正在將水楊酸添加到其配方中，以滿足市場對經過科學驗證的護膚產品的需求。艾伯維旗下子公司艾爾建美學於 2024 年 4 月推出了兩款新的「SkinMedica」痤瘡治療產品。 「痤瘡淨膚護理」和「毛孔淨化潔面啫咖哩」採用 2% 的包封水楊酸，可實現持續釋放並減少刺激。

替代方案的可用性

醫藥和化妝品領域替代活性成分的出現帶來了競爭壓力，尤其是在對成本敏感的細分市場，僅憑功效差異不足以支撐高價。 BETA-羥基酸（如水楊酸甜菜鹼）和α-羥基酸（如乙醇酸）具有與水楊酸類似的去角質效果，但刺激性可能更小，因此對於對水楊酸有副作用的敏感肌膚消費者來說，它們是頗具吸引力的選擇。在農業應用領域，合成植物生長調節劑和天然化合物都在爭奪市場佔有率，但水楊酸作為生長促進劑和抗病性增強劑的雙重作用使其具有競爭優勢。含有多種活性成分的複合產品的出現可能會降低對水楊酸作為單一成分的依賴，尤其是在多功能成分佔據高階地位的化妝品配方中。關鍵配方技術專利到期可能會加速非專利藥的競爭和替代成分的普及。市場動態有利於那些「功效與刺激性比率」更高的產品，這推動了水楊酸配方和競爭替代品的創新。

細分市場分析

粉末/晶體製劑憑藉成熟的生產流程和經濟高效的生產系統，預計到2025年將維持71.05%的市場佔有率，繼續引領市場。液體製劑則以7.12%的複合年成長率加速成長，主要得益於生產商對提高生物利用度和易用性的不懈追求。傳統的粉末製劑受益於其穩定性優勢和完善的供應鏈體系，在對劑量精準和保存期限要求極高的製藥應用中，其優勢尤為顯著。

在水楊酸市場，由於其優異的溶解性、高效的皮膚吸收性和易用性，液體製劑的應用日益廣泛。這些特性滿足了市場對即用型化妝品的需求，尤其是在痤瘡治療、去角質和護膚化妝水領域。水楊酸在穩定的液體基質中配製後，其功效得到增強。此外，經皮吸收貼片和緩釋凝膠等新型給藥系統，兼具固態製劑的穩定性及液體製劑的即時起效性。這些進步推動了市場對性能卓越、最大限度減少皮膚刺激並提供便捷使用方法的水楊酸產品的需求。

區域分析

憑藉完善的藥品生產基礎設施和嚴格的法規結構（該框架確保產品品質和安全標準檢驗），預計到2025年，歐洲將保持市場領先地位，市場佔有率達到30.78%。歐洲藥品管理局（EMA）和各國監管機構對該地區進行全面法律規範，這不僅增強了消費者對含水楊酸產品的信心，也為生產商建立了清晰的合規路徑。歐洲生產商利用先進的生產技術和成熟的分銷網路，向國內和出口市場供應產品，尤其在高附加價值藥品和化妝品應用領域實力雄厚。

亞太地區正崛起為成長最快的地區，預計到2031年將以9.44%的複合年成長率成長，這主要得益於不斷擴大的製藥產能、日益成長的農業應用以及消費者對個人保健產品中活性成分益處的認知不斷提高。中國透過對製造業的大規模投資，包括環境合規措施和採用先進製程技術的新生產設施的建設，引領該地區的成長。此外，北美是一個成熟的市場，擁有完善的法規結構和消費者對活性成分益處的廣泛認可，在藥品、化妝品和新興食品保鮮應用領域均呈現出穩定的需求模式。美國食品藥物管理局（FDA）針對水楊酸在各種應用中的使用提供了明確的指導，為產品開發和打入市場策略提供了監管確定性。

在南美和中東及非洲（MEA）市場，水楊酸預計將迎來成長機會，這主要得益於都市化、可支配收入的增加以及對藥品和個人保健產品需求的成長。巴西和墨西哥的國內藥品生產和非處方護膚品產業正在蓬勃發展，帶動了含水楊酸產品的普及。在中東及非洲（MEA）地區，消費者對個人衛生和皮膚健康的意識日益增強，導致痤瘡治療和去角質產品中對水楊酸的需求不斷成長。然而，市場成長也面臨產能有限、區域監管差異以及對進口的依賴等限制因素。全球製造商正致力於建立策略合作夥伴關係和在地化企業發展，以擴大市場佔有率並在這些地區建立更強大的供應鏈。

其他好處：

  • Excel格式的市場預測（ME）表
  • 3個月的分析師支持

目錄

第1章：引言

  • 研究假設和市場定義
  • 調查範圍

第2章：調查方法

第3章執行摘要

第4章 市場狀況

  • 市場概覽
  • 市場促進因素
    • 製藥業對水楊酸的需求增加
    • 對護膚和個人保健產品的需求增加
    • 「潔淨標示」飲料的保鮮方法審核數量增加
    • 在加工食品領域，對水楊酸作為食品防腐劑的需求正在增加。
    • 植物生長調節劑的需求日益成長
    • 消費者越來越偏好經過皮膚科測試的天然成分產品。
  • 市場限制因素
    • 替代方案的可用性
    • 原物料價格波動
    • 嚴格的法規核准和合規要求
    • 潛在的健康風險和皮膚過敏
  • 供應鏈分析
  • 監理展望
  • 波特五力分析

第5章 市場規模及成長預測（價值，百萬美元）

  • 透過使用
    • 製藥
    • 化妝品和個人護理
    • 食品/飲料
    • 其他
  • 按形式
    • 粉末/晶體
    • 液體
  • 按地區
    • 北美洲
      • 美國
      • 加拿大
      • 墨西哥
      • 其他北美國家
    • 歐洲
      • 德國
      • 法國
      • 英國
      • 西班牙
      • 義大利
      • 俄羅斯
      • 其他歐洲國家
    • 亞太地區
      • 中國
      • 印度
      • 日本
      • 澳洲
      • 其他亞太國家
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美國家
    • 中東和非洲
      • 南非
      • 沙烏地阿拉伯
      • 其他中東和非洲國家

第6章 競爭情勢

  • 市場集中度
  • 策略趨勢
  • 市場排名分析
  • 公司簡介
    • Seqens Group
    • Merck KGaA
    • Thermo Fisher Scientific
    • Cayman Chemical Company
    • Siddharth Carbochem Products
    • Lona Industries（Alta Laboratories）
    • SimSon Pharma Limited
    • Hebei Jingye Group
    • Zhenjiang Gaopeng Pharmaceutical
    • Spectrum Chemical Mfg
    • Avantor Inc.
    • Emco Group（Emco Dyestuff Pvt Ltd）
    • Alpha Chemika
    • Flychem Private Limited
    • Central Drug House
    • MedChemExpress
    • The Andhra Sugars Limited.
    • GFS Chemicals
    • Plater Group
    • Honeywell Research Chemical

第7章 市場機會與未來展望

簡介目錄
Product Code: 64897

According to Mordor Intelligence, the salicylic acid market size is expected to grow from USD 121.61 million in 2025 to USD 129.54 million in 2026 and is forecast to reach USD 177.61 million by 2031 at 6.52% CAGR over 2026-2031.

Salicylic Acid - Market - IMG1

This report is Segmented by Application (Pharmaceuticals, Cosmetics and Personal Care, Food and Beverages, and Others), Form (Powder/Crystal and Liquid), and Geography (North America, Europe, Asia-Pacific, South America, and Middle East and Africa). The Market Forecasts are Provided in Terms of Value (USD).

Global Salicylic Acid Market Trends and Insights

Increasing Demand for Salicylic Acid in the Pharmaceutical Industry

Pharmaceutical applications drive market expansion through expanding therapeutic indications and enhanced formulation technologies. Advanced delivery systems, particularly supramolecular formulations, demonstrate superior collagen density improvement and reduced skin irritation compared to conventional preparations, addressing historical limitations that constrained broader therapeutic adoption. Patent activity in pharmaceutical applications remains robust, with recent filings focusing on combination therapies and novel delivery mechanisms that enhance bioavailability while minimizing gastrointestinal side effects. The pharmaceutical segment benefits from established regulatory pathways and growing recognition of salicylic acid's anti-inflammatory properties beyond traditional dermatological applications. Moreover, the compound's established safety profile and regulatory approvals encourage manufacturers to incorporate it into various formulations. Key suppliers such as Hebei Jingye Group, Shandong Xinhua Company, and others play a significant role in producing pharmaceutical-grade salicylic acid for global markets. Finally, the surge in over-the-counter pharmaceutical products containing salicylic acid, driven by consumer preference for self-care solutions, also contributes significantly to the market's growth.

Rising Demand in Skincare and Personal Care Products

Consumer preference for scientifically validated active ingredients continues to drive the adoption of salicylic acid in cosmetic formulations. However, increasing regulatory scrutiny around safety is shaping how the ingredient is used. For instance, the European Commission's Scientific Committee on Consumer Safety recently limited the concentration of salicylic acid in children's cosmetic products to 0.1% for dermal applications, reflecting growing safety concerns while still allowing higher concentrations in adult products . In the United States, regulatory enforcement is also tightening, as evidenced by the United States Food and Drug Administration (FDA)'s warning letter to Skin Beauty Solutions regarding unapproved chemical peel products containing high concentrations of salicylic acid. This has prompted manufacturers to focus on developing compliant, safe formulations. Additionally, the Modernization of Cosmetics Regulation Act implements new registration requirements, increasing compliance standards and market entry protocols. Cosmetic and personal care manufacturers are integrating salicylic acid into formulations to address market demand for scientifically validated skincare products. Allergan Aesthetics, an AbbVie subsidiary, launched two SkinMedica products in April 2024 for acne treatment. The Acne Clarifying Treatment and Pore Purifying Gel Cleanser utilize 2% encapsulated salicylic acid for controlled release and reduced irritation.

Availability of Substitutes

Alternative active ingredients in pharmaceutical and cosmetic applications create competitive pressure, particularly in cost-sensitive market segments where efficacy differences may not justify premium pricing. Beta-hydroxy acids like betaine salicylate and alpha-hydroxy acids such as glycolic acid offer similar exfoliation benefits with potentially reduced irritation profiles, appealing to sensitive-skin consumers who experience adverse reactions to salicylic acid. In agricultural applications, synthetic plant growth regulators and alternative natural compounds compete for market share, though salicylic acid's dual role as both growth promoter and a disease resistance enhancer provides differentiation advantages. The availability of combination products that blend multiple active ingredients can reduce reliance on salicylic acid as a standalone component, particularly in cosmetic formulations where multi-functional ingredients command premium positioning. Patent expiration on key formulation technologies may accelerate generic competition and substitute adoption. Market dynamics favor products that demonstrate superior efficacy-to-irritation ratios, driving innovation in both salicylic acid formulations and competitive alternatives.

Other drivers and restraints analyzed in the detailed report include:

  1. Rise in Clean-Label Beverage Preservation Approvals
  2. Increasing Demand for Salicylic Acid in the Packaged Food Sector as a Food Preservative
  3. Price Volatility of Raw Materials

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Powder/crystal forms maintain market leadership with a 71.05% share in 2025, supported by established manufacturing processes and cost-effective production economics. Liquid formulations exhibit accelerated growth at 7.12% CAGR as manufacturers develop enhanced bioavailability and application convenience. Traditional powder forms benefit from stability advantages and established supply chain infrastructure, particularly in pharmaceutical applications where precise dosing and extended shelf life remain critical requirements.

The salicylic acid market demonstrates increased adoption of liquid formulations, attributed to their superior solubility, efficient skin absorption, and application convenience. These characteristics address market demand for ready-to-use cosmetic products, specifically in acne treatments, exfoliators, and clarifying toners. The efficacy of salicylic acid increases when formulated in stable liquid bases. Furthermore, emerging delivery systems, including transdermal patches and controlled-release gels, integrate the advantages of solid formulations' stability with liquid forms' rapid effectiveness. These advancements drive market demand for salicylic acid products that deliver optimal performance, minimize skin sensitivity, and provide efficient application methods.

Complete Report Scope:

  • By Application
    • Pharmaceuticals
    • Cosmetics and Personal Care
    • Food and Beverages
    • Others
  • By Form
    • Powder/Crystal
    • Liquid
  • By Geography
    • North America
      • United States
      • Canada
      • Mexico
      • Rest of North America
    • Europe
      • Germany
      • France
      • United Kingdom
      • Spain
      • Italy
      • Russia
      • Rest of Europe
    • Asia-Pacific
      • China
      • India
      • Japan
      • Australia
      • Rest of Asia-Pacific
    • South America
      • Brazil
      • Argentina
      • Rest of South America
    • Middle East and Africa
      • South Africa
      • Saudi Arabia
      • Rest of Middle East and Africa

Geography Analysis

Europe maintains market leadership with a 30.78% share in 2025, supported by established pharmaceutical manufacturing infrastructure and stringent regulatory frameworks that validate product quality and safety standards. The region benefits from comprehensive regulatory oversight through the European Medicines Agency and national authorities, creating consumer confidence in salicylic acid-containing products while establishing clear compliance pathways for manufacturers. European manufacturers leverage advanced production technologies and established distribution networks to serve both domestic and export markets, with particular strength in high-value pharmaceutical and cosmetic applications.

The Asia-Pacific region emerges as the fastest-growing region, with a 9.44% CAGR through 2031, driven by expanding pharmaceutical manufacturing capacity, increasing agricultural applications, and rising consumer awareness of the benefits of active ingredients in personal care products. China leads regional growth through significant investments in manufacturing, including the establishment of new production facilities that incorporate environmental compliance measures and advanced process technologies. Moreover, North America represents a mature market with stable demand patterns across pharmaceutical, cosmetic, and emerging food preservation applications, supported by comprehensive regulatory frameworks and established consumer acceptance of active ingredient benefits. The United States Food and Drug Administration (FDA)'s clear guidance on salicylic acid use in various applications provides regulatory certainty that supports product development and market entry strategies.

South America, and Middle East and Africa (MEA) markets present growth opportunities for salicylic acid, driven by urbanization, higher disposable incomes, and increased demand for pharmaceutical and personal care products. Brazil and Mexico are experiencing growth in their domestic pharmaceutical manufacturing and over-the-counter skincare segments, leading to increased adoption of salicylic acid formulations. The Middle East and Africa (MEA) region shows increased consumer awareness of personal hygiene and skin health, resulting in higher demand for salicylic acid in acne treatments and exfoliating products. However, market growth faces constraints from limited manufacturing capabilities, varying regulations across regions, and dependence on imports. Global manufacturers are focusing on strategic partnerships and local presence to expand their market reach and establish stronger supply chains in these regions.

  1. Seqens Group
  2. Merck KGaA
  3. Thermo Fisher Scientific
  4. Cayman Chemical Company
  5. Siddharth Carbochem Products
  6. Lona Industries (Alta Laboratories)
  7. SimSon Pharma Limited
  8. Hebei Jingye Group
  9. Zhenjiang Gaopeng Pharmaceutical
  10. Spectrum Chemical Mfg
  11. Avantor Inc.
  12. Emco Group (Emco Dyestuff Pvt Ltd)
  13. Alpha Chemika
  14. Flychem Private Limited
  15. Central Drug House
  16. MedChemExpress
  17. The Andhra Sugars Limited.
  18. GFS Chemicals
  19. Plater Group
  20. Honeywell Research Chemical

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET LANDSCAPE

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Demand for Salicylic Acid in the Pharmaceutical Industry
    • 4.2.2 Rising Demand in Skincare and Personal Care Products
    • 4.2.3 Rise in Clean-Label Beverage Preservation Approvals
    • 4.2.4 Increasing Demand for Salicylic Acid in the Packaged Food Sector as a Food Preservative
    • 4.2.5 Growing Need for Plant Growth Regulators
    • 4.2.6 Increasing Consumer Preference for Dermatologically Tested and Natural Ingredients
  • 4.3 Market Restraints
    • 4.3.1 Availability of Substitutes
    • 4.3.2 Price Volatality of Raw materials
    • 4.3.3 Stringent Regulatory Approvals and Compliance Requirements
    • 4.3.4 Potential Health Risks and Skin Sensitivities
  • 4.4 Supply-Chain Analysis
  • 4.5 Regulatory Outlook
  • 4.6 Porter's Five Forces Analysis
    • 4.6.1 Threat of New Entrants
    • 4.6.2 Bargaining Power of Buyers
    • 4.6.3 Bargaining Power of Suppliers
    • 4.6.4 Threat of Substitutes
    • 4.6.5 Competitive Rivalry

5 MARKET SIZE AND GROWTH FORECASTS (VALUE, USD MN)

  • 5.1 By Application
    • 5.1.1 Pharmaceuticals
    • 5.1.2 Cosmetics and Personal Care
    • 5.1.3 Food and Beverages
    • 5.1.4 Others
  • 5.2 By Form
    • 5.2.1 Powder/Crystal
    • 5.2.2 Liquid
  • 5.3 By Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
      • 5.3.1.4 Rest of North America
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 France
      • 5.3.2.3 United Kingdom
      • 5.3.2.4 Spain
      • 5.3.2.5 Italy
      • 5.3.2.6 Russia
      • 5.3.2.7 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 India
      • 5.3.3.3 Japan
      • 5.3.3.4 Australia
      • 5.3.3.5 Rest of Asia-Pacific
    • 5.3.4 South America
      • 5.3.4.1 Brazil
      • 5.3.4.2 Argentina
      • 5.3.4.3 Rest of South America
    • 5.3.5 Middle East and Africa
      • 5.3.5.1 South Africa
      • 5.3.5.2 Saudi Arabia
      • 5.3.5.3 Rest of Middle East and Africa

6 COMPETITIVE LANDSCAPE

  • 6.1 Market Concentration
  • 6.2 Strategic Moves
  • 6.3 Market Ranking Analysis
  • 6.4 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products and Services, and Recent Developments)
    • 6.4.1 Seqens Group
    • 6.4.2 Merck KGaA
    • 6.4.3 Thermo Fisher Scientific
    • 6.4.4 Cayman Chemical Company
    • 6.4.5 Siddharth Carbochem Products
    • 6.4.6 Lona Industries (Alta Laboratories)
    • 6.4.7 SimSon Pharma Limited
    • 6.4.8 Hebei Jingye Group
    • 6.4.9 Zhenjiang Gaopeng Pharmaceutical
    • 6.4.10 Spectrum Chemical Mfg
    • 6.4.11 Avantor Inc.
    • 6.4.12 Emco Group (Emco Dyestuff Pvt Ltd)
    • 6.4.13 Alpha Chemika
    • 6.4.14 Flychem Private Limited
    • 6.4.15 Central Drug House
    • 6.4.16 MedChemExpress
    • 6.4.17 The Andhra Sugars Limited.
    • 6.4.18 GFS Chemicals
    • 6.4.19 Plater Group
    • 6.4.20 Honeywell Research Chemical

7 MARKET OPPORTUNITIES AND FUTURE OUTLOOK